.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have recently introduced PathoFact 2.0, a sophisticated bioinformatics pipeline specifically designed for antimicrobial resistance gene prediction. Antimicrobial resistance (AMR) remains a critical threat to global health. Consequently, tools that accurately identify resistance markers are essential for clinical research. PathoFact 2.0 improves upon its predecessor by integrating advanced machine learning models and expanded databases. This tool allows scientists to analyze metagenomic data to pinpoint virulence factors, toxins, and resistance genes simultaneously.
The updated pipeline features a refined machine learning model for identifying virulence factors (VFs). Additionally, it introduces a dedicated model for toxins and toxin-associated proteins. These upgrades ensure higher accuracy and broader coverage than earlier versions. Furthermore, the integration of antiSMASH 7.0 enables the prediction of biosynthetic gene clusters (BGCs). Specifically, this addition helps researchers understand the metabolic potential of microbial communities. By combining these capabilities, PathoFact 2.0 provides a holistic view of microbial pathogenicity.
One of the primary strengths of PathoFact 2.0 is its expanded hidden Markov model (HMM) profiles. These profiles significantly enhance the antimicrobial resistance gene prediction process. Moreover, the tool's compatibility with Linux environments facilitates high-throughput analysis in specialized laboratories. Therefore, clinicians and researchers can better track the spread of drug-resistant pathogens. This comprehensive approach is vital for developing targeted interventions against infectious diseases. Ultimately, PathoFact 2.0 serves as a powerful resource for addressing the complex challenges of AMR.
PathoFact 2.0 is an integrative bioinformatics pipeline used to predict antimicrobial resistance genes, virulence factors, and toxins from metagenomic datasets.
The 2.0 version includes updated machine learning models, expanded HMM profiles, and the integration of antiSMASH 7.0 for predicting biosynthetic gene clusters.
PathoFact 2.0 is developed for and compatible with Linux operating systems.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional diagnostic services. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Delgado LF et al. PathoFact 2.0: An Integrative Pipeline for the Prediction of Antimicrobial Resistance Genes, Virulence Factors, Toxins and Toxin-associated Proteins, and Biosynthetic Gene Clusters in Metagenomes. Gigascience. 2026 May 22. doi: undefined. PMID: 42172047.
de Nies L et al. PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data. Microbiome. 2021 Feb 17;9(1):49. doi: 10.1186/s40168-020-00993-9. PMID: 33597026.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
PathoFact 2.0 is an upgraded pipeline for predicting antimicrobial resistance genes, virulence factors, and toxins using advanced machine learning models....
3 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
